NOS

INOSINE

Created: 1999-07-08
Last modified:  2018-09-13

Find related ligands:

Chemical Details

Formal Charge0
Atom Count31
Chiral Atom Count4
Bond Count33
Aromatic Bond Count5
2D diagram of NOS

Chemical Component Summary

NameINOSINE
Systematic Name (OpenEye OEToolkits)9-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolan-2-yl]-1~{H}-purin-6-one
FormulaC10 H12 N4 O5
Molecular Weight268.226
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESCACTVS3.385OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3C(=O)NC=Nc23
SMILESOpenEye OEToolkits2.0.6c1nc2c(n1C3C(C(C(O3)CO)O)O)N=CNC2=O
Canonical SMILESCACTVS3.385 OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3C(=O)NC=Nc23
Canonical SMILESOpenEye OEToolkits2.0.6 c1nc2c(n1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=CNC2=O
InChIInChI1.03 InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1
InChIKeyInChI1.03 UGQMRVRMYYASKQ-KQYNXXCUSA-N

Drug Info: DrugBank

DrugBank IDDB04335 
NameInosine
Groups
  • experimental
  • investigational
DescriptionA purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
Synonyms
  • 9-β-D-ribofuranosyl-9H-purin-6-ol
  • INO
  • beta-Inosine
  • 9-β-D-ribofuranosylhypoxanthine
  • Inosin
Brand NamesRejuvesol
IndicationThe primary popular claim made for inosine, that it enhances exercise and athletic performance, is refuted by the available research data. There is some preliminary evidence that inosine may have some neurorestorative, anti-inflammatory, immunomodulatory and cardioprotective effects.
Categories
  • Dermatologicals
  • Genito Urinary System and Sex Hormones
  • Gynecological Antiinfectives and Antiseptics
  • Heterocyclic Compounds, Fused-Ring
  • Nucleic Acids, Nucleotides, and Nucleosides
ATC-Code
  • G01AX02
  • S01XA10
  • D06BB05
CAS number58-63-9

Drug Targets

NameTarget SequencePharmacological ActionActions
Purine nucleoside phosphorylaseMENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDY...unknown
IAG-nucleoside hydrolaseMAKNVVLDHDGNLDDFVAMVLLASNTEKVRLIGALCTDADCFVENGFNVT...unknown
Purine nucleoside phosphorylase DeoD-typeMATPHINAEMGDFADVVLMPGDPLRAKYIAETFLEDAREVNNVRGMLGFT...unknown
Xanthine dehydrogenase/oxidaseMTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEGGCGA...unknownsubstrate,inducer
Solute carrier family 28 member 3MELRSTAAPRAEGYSNVGFQNEENFLENENTSGNNSIRSRAVQSREHTNT...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 6021, 5274258, 135398641
ChEMBL CHEMBL1556
ChEBI CHEBI:17596
CCDC/CSD INOSND10, INOSIN10, XEHKAA